According to United Therapeutics's latest financial reports the company's current earnings are A$2.87 Billion. , an increase over its 2023 earnings that were of A$2.13 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | A$2.52 B | 18.62% |
2023 | A$2.13 B | 35.67% |
2022 | A$1.57 B | 60.49% |
2021 | A$0.97 B | -7.53% |
2020 | A$1.05 B | -648.34% |
2019 | -A$0.2 Billion | -115.63% |
2018 | A$1.23 B | -0.73% |
2017 | A$1.24 B | -26.84% |
2016 | A$1.70 B | 1.42% |
2015 | A$1.67 B | 93.3% |
2014 | A$0.86 B | 82.78% |
2013 | A$0.47 B | -35.06% |
2012 | A$0.73 B | 42.34% |
2011 | A$0.51 B | 90.62% |
2010 | A$0.26 B | 432.71% |
2009 | A$50.6 M | -144.9% |
2008 | -A$0.12 Billion | -1218.11% |
2007 | A$10.07 M | -78.26% |
2006 | A$46.34 M | -32.43% |
2005 | A$68.59 M | 224.69% |
2004 | A$21.12 M | -214.61% |
2003 | -A$18.44 Million | -35.98% |
2002 | -A$28.8 Million | |
2000 | -A$0.14 Billion | 132.2% |
1999 | -A$56.14 Million |